Skip to main content
N

NKY Medical Holdings Ltd. — Investor Relations & Filings

Ticker · 300109 ISIN · CNE100000SV3 LEI · 300300WRQJEGI6005N04 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,621 across all filing types
Latest filing 2026-06-01 Transaction in Own Shar…
Country CN China
Listing Shenzhen Stock Exchange 300109

About NKY Medical Holdings Ltd.

https://www.nkygroup.cn、www.boai-nky.com

NKY Medical Holdings Ltd. specializes in the research, development, and production of polyvinylpyrrolidone (PVP) series products and specialty polymers. The company’s core portfolio includes PVP K-series, Povidone-Iodine (PVP-I), Crospovidone (PVPP), and Vinylpyrrolidone/Vinyl Acetate (PVP/VA) copolymers. These products function as essential excipients, binders, and disintegrants within the pharmaceutical sector, and are also utilized in cosmetics, food processing, and industrial applications such as coatings and adhesives. In addition to its chemical manufacturing operations, the company provides medical services and high-end medical consumables. NKY focuses on high-purity chemical solutions and maintains international quality standards, including GMP and ISO certifications, to support its global supply chain and technical service offerings.

Recent filings

Filing Released Lang Actions
关于回购公司股份进展的公告
Transaction in Own Shares Classification · 92% confidence The document is a company announcement detailing the progress of its share repurchase (number of shares repurchased, price range, total amount, compliance with regulations). This is a classic “company buying back its own shares” announcement, which corresponds to the “Transaction in Own Shares” category.
2026-06-01 Chinese
关于回购公司股份比例达到2%暨回购进展的公告
Transaction in Own Shares Classification · 92% confidence The document is an announcement by 博爱新开源医疗科技集团股份有限公司 regarding its ongoing share repurchase plan, detailing the number of shares repurchased, percentage of total share capital (2.03%), prices, amounts, and compliance with relevant regulations. It is not an earnings release, financial report, or proxy solicitation, but clearly a report on transactions in the company's own shares. Therefore, it falls under the category 'Transaction in Own Shares' (POS).
2026-05-27 Chinese
北京大成律师事务所关于博爱新开源医疗科技集团股份有限公司2025年年度股东会之法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is a legal opinion letter by the company’s law firm regarding the convening, procedural compliance, attendance, agenda, voting process, and detailed vote tallies at the 2025 Annual Shareholders’ Meeting. It is not a standalone financial report, earnings release, or management discussion, but it does contain the official voting results and legal validation of those results at the AGM. Accordingly, it best fits “Declaration of Voting Results & Voting Rights Announcements” (DVA).
2026-05-15 Chinese
关于公司董事会完成换届选举暨聘任高级管理人员、证券事务代表的公告
Board/Management Information Classification · 85% confidence The document is an official announcement by the company regarding the completion of its board re-election and the appointment of senior management and securities affairs representatives. It details changes in the board composition and senior management roles, with no financial statements or shareholder voting results beyond board elections. This aligns exactly with the definition for Board/Management Information (MANG).
2026-05-15 Chinese
关于选举第六届董事会职工代表董事的公告
Board/Management Information Classification · 92% confidence The document is an announcement by the company and its board regarding the election of an employee representative director (board member). It details the board composition change, election procedures, and qualifications of the elected director. This clearly falls under Board/Management Information (MANG) as it is a change in the company's board structure rather than a financial report or other category.
2026-05-15 Chinese
第六届董事会第一次会议决议公告
Board/Management Information Classification · 92% confidence The document is a board meeting resolution announcement detailing the election of the board chairman, vice chairman, committee members and the appointment of senior management (general manager, deputy general managers, CFO, board secretary, securities rep). This clearly falls under announcements of changes in the company’s board of directors and senior management, matching the Board/Management Information category.
2026-05-15 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.